Biotech and Life Sciences jobs in Cambridge hiring now at vetted startups and product companies on Alion, updated daily. Average salary around $238,715/year. Compare remote, hybrid and on-site positions with relocation and visa sponsorship. Browse and apply today.
You searched for “Biotech and Life Sciences Jobs in Cambridge”, so this list shows: Biotech and Life Sciences roles · an office in Cambridge · known staffing agencies left out. Adjust the filters
regeneron.com · HQ: Tarrytown, United States · Oncology Therapeutics · Immunology & Inflammation Therapeutics · Prescription Drugs · Biologics & Biosimilars · 5000+ employees · Est. 1988 · NASDAQ: REGN · Trust B · Hiring 494, 52 new
HQ: Tarrytown, United States · Oncology Therapeutics · Immunology & Inflammation Therapeutics · Prescription Drugs · Biologics & Biosimilars · 5000+ employees · Est. 1988 · NASDAQ: REGN · Trust B · Hiring 494, 52 new
Regeneron Pharmaceuticals is an American biotechnology company headquartered in Tarrytown, New York, that discovers, develops and manufactures antibody and other biologic medicines. Founded in 1988 and listed on Nasdaq, its products include the eye disease treatment Eylea, the immunology drug Dupixent developed with Sanofi, the cancer immunotherapy Libtayo and the cholesterol drug Praluent. It uses its VelociSuite mouse technologies and the Regeneron Genetics Center to find drug targets, and runs large manufacturing sites in Rensselaer, New York, and Limerick, Ireland.
bms.com · HQ: Princeton, United States · Cardiometabolic Therapeutics · Biologics & Biosimilars · Oncology Therapeutics · Prescription Drugs · 5000+ employees · Est. 1887 · Trust A · Hiring 380, 60 new
HQ: Princeton, United States · Cardiometabolic Therapeutics · Biologics & Biosimilars · Oncology Therapeutics · Prescription Drugs · 5000+ employees · Est. 1887 · Trust A · Hiring 380, 60 new
Bristol Myers Squibb is an American pharmaceutical company whose predecessors date to 1858 and 1887 and which took its present form in a 1989 merger. Its portfolio is concentrated in oncology, haematology, immunology and cardiovascular disease, including the checkpoint inhibitor Opdivo, the blood thinner Eliquis co-marketed with Pfizer, the cell therapies acquired with Celgene, and newer products such as the schizophrenia treatment Cobenfy. Headquartered in Princeton, New Jersey and listed on the New York Stock Exchange, it faces a heavy sequence of patent expiries and has been buying and licensing assets to replace them.
$253k – $306k per year · Head+ · 12+ years exp · In office (Cambridge, San Diego, Princeton, United States, Brisbane, Australia) · PhD · Full-Time · Senior
$60k – $90k per year · Intern · 1+ year exp · In office (Princeton, Madison, Seattle, Cambridge, San Diego, United States) · Master's Degree · Internship · Intern
Novartis is a Swiss pharmaceutical company created in 1996 by the merger of Ciba-Geigy and Sandoz, two Basel chemical and drug houses with roots in the nineteenth century. It has spent the past decade narrowing itself into a pure innovative medicines business, spinning off its generics arm as Sandoz in 2023 and its eye care business as Alcon in 2019, and now concentrates on cardiovascular, immunology, neuroscience and oncology, including radioligand therapies and gene therapy. Headquartered in Basel and listed in Zurich and New York, it is among the largest research spenders in the industry.
sanofi.com · HQ: Paris, France · Vaccines · Rare Disease Therapeutics · Immunology & Inflammation Therapeutics · Prescription Drugs · 5000+ employees · Est. 1973 · NASDAQ: SNY · Trust A · Hiring 728, 132 new
HQ: Paris, France · Vaccines · Rare Disease Therapeutics · Immunology & Inflammation Therapeutics · Prescription Drugs · 5000+ employees · Est. 1973 · NASDAQ: SNY · Trust A · Hiring 728, 132 new
Sanofi is a French pharmaceutical company formed in 1973 and assembled over five decades through a long series of mergers including Synthelabo, Aventis and Genzyme. It is now built around immunology and rare disease, with Dupixent for atopic dermatitis and asthma as by far its largest product, alongside a substantial vaccines division covering influenza, meningitis and the respiratory syncytial virus antibody Beyfortus. Headquartered in Paris, the group has sharpened its focus in recent years by separating its consumer healthcare business into the standalone company Opella and directing research spending toward biologics and immune science.
flagshippioneering.com · HQ: Cambridge, United States · Venture Capital · 1001-5000 employees · Est. 2000 · Trust B · Hiring 92, 10 new
HQ: Cambridge, United States · Venture Capital · 1001-5000 employees · Est. 2000 · Trust B · Hiring 92, 10 new
Flagship Pioneering is a life sciences venture creation firm headquartered in Cambridge, Massachusetts, that conceives, founds, funds and builds biotechnology companies. Founded in 2000 by Noubar Afeyan, it has created companies such as Moderna and runs in-house laboratories where its scientists develop platforms before they are spun out as new ventures. It hires scientists in protein science, structural biology, biochemistry and formulation, machine learning interns and platform leaders, mostly in Cambridge.
takeda.com · HQ: Tokyo, Japan · Neurology & CNS Therapeutics · Rare Disease Therapeutics · Oncology Therapeutics · Prescription Drugs · 5000+ employees · Est. 1781 · Trust A · Hiring 1137, 137 new
HQ: Tokyo, Japan · Neurology & CNS Therapeutics · Rare Disease Therapeutics · Oncology Therapeutics · Prescription Drugs · 5000+ employees · Est. 1781 · Trust A · Hiring 1137, 137 new
Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise specializing in the research, development, and commercialization of targeted human therapeutics. The company focuses on core therapeutic areas including oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies, and vaccines. Headquartered in Tokyo, Japan, it maintains extensive research, manufacturing, and commercial operations across more than 80 countries in Asia-Pacific, North America, Europe, and Latin America.
broadinstitute.org · HQ: Cambridge, United States · Nonprofits & Foundations · Genomics & Genetic Testing · Bioinformatics · Research Institutes · 501-1000 employees · Est. 2004 · Hiring 28, 3 new
HQ: Cambridge, United States · Nonprofits & Foundations · Genomics & Genetic Testing · Bioinformatics · Research Institutes · 501-1000 employees · Est. 2004 · Hiring 28, 3 new
The Broad Institute is a biomedical and genomic research centre founded jointly by MIT and Harvard to tackle problems that need scale beyond a single university laboratory. Its data sciences platform develops machine learning methods for genomics, cancer biology and drug discovery, and maintains widely used open tools, datasets and cloud analysis platforms. The institute also runs one of the largest genome sequencing operations in the world; its researchers work jointly with the two universities and with hospitals across the Boston area.
sarepta.com · HQ: Cambridge, United States · Cell & Gene Therapy · Rare Disease Therapeutics · 501-1000 employees · Hiring 9, 1 new
HQ: Cambridge, United States · Cell & Gene Therapy · Rare Disease Therapeutics · 501-1000 employees · Hiring 9, 1 new
We are focused on the development of precision genetic medicines to treat rare neuromuscular and central nervous system diseases. Learn more about Sarepta.
biogen.com · HQ: Cambridge, United States · Prescription Drugs · Neurology & CNS Therapeutics · 5000+ employees · Est. 1978 · NASDAQ: BIIB · Trust B · Hiring 185, 17 new
HQ: Cambridge, United States · Prescription Drugs · Neurology & CNS Therapeutics · 5000+ employees · Est. 1978 · NASDAQ: BIIB · Trust B · Hiring 185, 17 new
Biogen is an American biotechnology company headquartered in Cambridge, Massachusetts, that develops and sells therapies for neurological and neurodegenerative diseases. Founded in 1978, its products treat multiple sclerosis, spinal muscular atrophy, Alzheimer's disease and other rare and neuromuscular disorders. It is listed on Nasdaq and hires regulatory, manufacturing, medical science liaison and IT staff in Cambridge, Research Triangle Park, Baar and other sites.
iconplc.com · HQ: Dublin, Ireland · Clinical Trial Services (CRO) · 5000+ employees · Est. 1990 · Trust A · Hiring 702, 98 new
HQ: Dublin, Ireland · Clinical Trial Services (CRO) · 5000+ employees · Est. 1990 · Trust A · Hiring 702, 98 new
ICON is an Irish clinical research organisation that provides outsourced clinical development and commercialisation services to pharmaceutical, biotechnology and medical device companies, from early-phase trials to late-stage studies, laboratory services and real-world evidence. Founded in 1990 and listed on Nasdaq, it operates worldwide with tens of thousands of employees. The company is headquartered in Dublin, Ireland.
pfizer.com · HQ: New York, United States · Infectious Disease Therapeutics · Oncology Therapeutics · Prescription Drugs · 5000+ employees · Est. 1849 · Trust A · Hiring 377, 115 new
HQ: New York, United States · Infectious Disease Therapeutics · Oncology Therapeutics · Prescription Drugs · 5000+ employees · Est. 1849 · Trust A · Hiring 377, 115 new
Pfizer is an American multinational pharmaceutical and biotechnology company headquartered in New York City, developing, manufacturing and marketing prescription medicines and vaccines in areas such as oncology, internal medicine, inflammation and immunology, and infectious diseases. Founded in 1849 by Charles Pfizer and Charles Erhart, it is listed on the New York Stock Exchange and operates research and manufacturing sites across the US, Europe and Asia, including a digital hub in Thessaloniki and large commercial teams in China. Its board hires medical information specialists, quality assurance and GMP audit managers, marketing leads, accountants, engineers and AI experience designers.
$139k – $232k per year · Senior · 6+ years exp · Hybrid (San Diego, Lake Forest, Cambridge, New York, United States) · Relocation · PhD · Full-Time · Senior
astrazeneca.com · HQ: Cambridge, United Kingdom · Rare Disease Therapeutics · Cardiometabolic Therapeutics · Oncology Therapeutics · Prescription Drugs · 5000+ employees · Est. 1999 · Trust A · Hiring 899, 177 new
HQ: Cambridge, United Kingdom · Rare Disease Therapeutics · Cardiometabolic Therapeutics · Oncology Therapeutics · Prescription Drugs · 5000+ employees · Est. 1999 · Trust A · Hiring 899, 177 new
AstraZeneca is a British-Swedish pharmaceutical company formed in 1999 by the merger of Astra of Sweden and Zeneca of the United Kingdom, and now one of the largest drug makers in the world by revenue. Its portfolio is concentrated in oncology with Tagrisso, Imfinzi and Enhertu, alongside cardiovascular, renal and metabolic products including Farxiga, respiratory and immunology medicines, and a rare disease business built on the acquisition of Alexion. Headquartered in Cambridge in England and listed in London, Stockholm and New York, it reports in United States dollars.
abbvie.com · HQ: North Chicago, Blacksburg, United States · Neurology & CNS Therapeutics · Oncology Therapeutics · Immunology & Inflammation Therapeutics · Prescription Drugs · 5000+ employees · Est. 2013 · NYSE: ABBV · Trust B · Hiring 1137, 217 new
HQ: North Chicago, Blacksburg, United States · Neurology & CNS Therapeutics · Oncology Therapeutics · Immunology & Inflammation Therapeutics · Prescription Drugs · 5000+ employees · Est. 2013 · NYSE: ABBV · Trust B · Hiring 1137, 217 new
AbbVie is an American biopharmaceutical company created in 2013 when Abbott Laboratories separated its research-based drug business into a standalone listed company. It was built around the immunology drug Humira, once the highest selling medicine in the world, and has since replaced that revenue with the successor immunology drugs Skyrizi and Rinvoq, an oncology portfolio led by Imbruvica and Venclexta, neuroscience products including Botox Therapeutic and Vraylar, and the aesthetics business acquired with Allergan. Headquartered in North Chicago and listed on the New York Stock Exchange, it is one of the largest pharmaceutical companies by revenue.
alnylam.com · HQ: Cambridge, United States · Cardiometabolic Therapeutics · Rare Disease Therapeutics · Cell & Gene Therapy · 1001-5000 employees · Est. 2002 · Hiring 89, 5 new
HQ: Cambridge, United States · Cardiometabolic Therapeutics · Rare Disease Therapeutics · Cell & Gene Therapy · 1001-5000 employees · Est. 2002 · Hiring 89, 5 new
Alnylam Pharmaceuticals is a biopharmaceutical company headquartered in Cambridge, Massachusetts, that develops and commercialises RNA interference therapeutics for rare and common diseases, including ATTR amyloidosis and acute hepatic porphyria. Founded in Cambridge in 2002 and listed on the Nasdaq, it has six approved medicines available in more than 70 countries, a manufacturing site in Norton, Massachusetts, a European base in Maidenhead and an affiliate in Tokyo. It hires research and biology scientists, quality control analysts, clinical science and regulatory affairs staff, field reimbursement and key account managers, and IT, cyber defense and HR technology leaders.
amylyx.com · Cambridge · Stockholm · Cork · Chicago · Rare Disease Therapeutics · 51-200 employees · Trust B · Hiring 47, 10 new
Cambridge · Stockholm · Cork · Chicago · Rare Disease Therapeutics · 51-200 employees · Trust B · Hiring 47, 10 new
Ushering in a new era for treating diseases with high unmet needs. We have an audacious mission to develop novel therapies for communities with high unmet needs. Where others see obstacles, the Amylyx team sees opportunities to find solutions for some of medicine's toughest challenges.
BioNTech is a German biotechnology company founded in Mainz in 2008 by the physician-scientists Ugur Sahin and Ozlem Tureci to develop individualised cancer immunotherapies using messenger RNA. Its mRNA platform, refined over a decade on oncology programmes, was redirected in early 2020 to produce Comirnaty with Pfizer, the first COVID-19 vaccine authorised in the West and the source of tens of billions of euros in revenue. The company has reinvested that windfall into its original mission, running a broad clinical pipeline of mRNA cancer vaccines, individualised neoantigen therapies and bispecific antibodies including the closely watched BNT327 programme.
gsk.com · HQ: London, United Kingdom · Oncology Therapeutics · Infectious Disease Therapeutics · Vaccines · Prescription Drugs · 5000+ employees · Est. 2000 · Trust A · Hiring 590, 111 new
HQ: London, United Kingdom · Oncology Therapeutics · Infectious Disease Therapeutics · Vaccines · Prescription Drugs · 5000+ employees · Est. 2000 · Trust A · Hiring 590, 111 new
GSK is a British multinational pharmaceutical company that develops and manufactures prescription medicines and vaccines, with research focused on infectious diseases, HIV, respiratory and immunology, and oncology. It was formed in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham and spun off its consumer healthcare business as Haleon in 2022. Listed in London and New York, it runs research, manufacturing and commercial operations worldwide. The company is headquartered in London, England, United Kingdom.
modernatx.com · HQ: Cambridge, United States · Vaccines · Infectious Disease Therapeutics · Prescription Drugs · 1001-5000 employees · Est. 2010 · NASDAQ: MRNA · Trust A · Hiring 192, 5 new
HQ: Cambridge, United States · Vaccines · Infectious Disease Therapeutics · Prescription Drugs · 1001-5000 employees · Est. 2010 · NASDAQ: MRNA · Trust A · Hiring 192, 5 new
Moderna is a global pharmaceutical and biotechnology enterprise pioneering messenger RNA therapeutics and vaccines. The company focuses on discovering and developing mRNA-based medicines to prevent and treat infectious diseases, immuno-oncology, and rare conditions. Headquartered in Cambridge, Massachusetts, it operates advanced research, development, and manufacturing networks worldwide to advance preventive and therapeutic health solutions.